Cargando…

Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial

BACKGROUND: Infusion therapy is one of the most frequently prescribed medications in hospitalized patients. Currently used crystalloid solutes have a variable composition and may therefore influence acid-base status, intracellular and extracellular water content and plasma electrolyte compositions a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfortmueller, Carmen, Funk, Georg-Christian, Potura, Eva, Reiterer, Christian, Luf, Florian, Kabon, Barbara, Druml, Wilfred, Fleischmann, Edith, Lindner, Gregor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599439/
https://www.ncbi.nlm.nih.gov/pubmed/28255797
http://dx.doi.org/10.1007/s00508-017-1180-4
_version_ 1783264056065392640
author Pfortmueller, Carmen
Funk, Georg-Christian
Potura, Eva
Reiterer, Christian
Luf, Florian
Kabon, Barbara
Druml, Wilfred
Fleischmann, Edith
Lindner, Gregor
author_facet Pfortmueller, Carmen
Funk, Georg-Christian
Potura, Eva
Reiterer, Christian
Luf, Florian
Kabon, Barbara
Druml, Wilfred
Fleischmann, Edith
Lindner, Gregor
author_sort Pfortmueller, Carmen
collection PubMed
description BACKGROUND: Infusion therapy is one of the most frequently prescribed medications in hospitalized patients. Currently used crystalloid solutes have a variable composition and may therefore influence acid-base status, intracellular and extracellular water content and plasma electrolyte compositions and have a major impact on organ function and outcome. The aim of our study was to investigate whether use of acetate-based balanced crystalloids leads to better hemodynamic stability compared to 0.9% saline. METHODS: We performed a sub-analysis of a prospective, randomized, controlled trial comparing effects of 0.9% saline or an acetate-buffered, balanced crystalloid during the perioperative period in patients with end-stage renal disease undergoing cadaveric renal transplantation. Need for catecholamine therapy and blood pressure were the primary measures. RESULTS: A total of 150 patients were included in the study of which 76 were randomized to 0.9% saline while 74 received an acetate-buffered balanced crystalloid. Noradrenaline for cardiocirculatory support during surgery was significantly more often administered in the normal saline group, given earlier and with a higher cumulative dose compared to patients receiving an acetate-buffered balanced crystalloid (30% versus 15%, p = 0.027; 68 ± 45 µg/kg versus 75 ± 60 µg/kg, p = 0.0055 and 0.000492 µg/kg body weight/min, ±0.002311 versus 0.000107 µg/kg/min, ±0.00039, p = 0.04, respectively). Mean minimum arterial blood pressure was significantly lower in patients randomized to 0.9% saline than in patients receiving the balanced infusion solution (57.2 [SD 8.7] versus 60.3 [SD 10.2] mm Hg, p = 0.024). CONCLUSION: The use of an acetate-buffered, balanced infusion solution results in reduced need for use of catecholamines and cumulative catecholamine dose for hemodynamic support and in less occurrence of arterial hypotension in the perioperative period. Further research in the field is strongly encouraged.
format Online
Article
Text
id pubmed-5599439
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-55994392017-10-03 Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial Pfortmueller, Carmen Funk, Georg-Christian Potura, Eva Reiterer, Christian Luf, Florian Kabon, Barbara Druml, Wilfred Fleischmann, Edith Lindner, Gregor Wien Klin Wochenschr Original Article BACKGROUND: Infusion therapy is one of the most frequently prescribed medications in hospitalized patients. Currently used crystalloid solutes have a variable composition and may therefore influence acid-base status, intracellular and extracellular water content and plasma electrolyte compositions and have a major impact on organ function and outcome. The aim of our study was to investigate whether use of acetate-based balanced crystalloids leads to better hemodynamic stability compared to 0.9% saline. METHODS: We performed a sub-analysis of a prospective, randomized, controlled trial comparing effects of 0.9% saline or an acetate-buffered, balanced crystalloid during the perioperative period in patients with end-stage renal disease undergoing cadaveric renal transplantation. Need for catecholamine therapy and blood pressure were the primary measures. RESULTS: A total of 150 patients were included in the study of which 76 were randomized to 0.9% saline while 74 received an acetate-buffered balanced crystalloid. Noradrenaline for cardiocirculatory support during surgery was significantly more often administered in the normal saline group, given earlier and with a higher cumulative dose compared to patients receiving an acetate-buffered balanced crystalloid (30% versus 15%, p = 0.027; 68 ± 45 µg/kg versus 75 ± 60 µg/kg, p = 0.0055 and 0.000492 µg/kg body weight/min, ±0.002311 versus 0.000107 µg/kg/min, ±0.00039, p = 0.04, respectively). Mean minimum arterial blood pressure was significantly lower in patients randomized to 0.9% saline than in patients receiving the balanced infusion solution (57.2 [SD 8.7] versus 60.3 [SD 10.2] mm Hg, p = 0.024). CONCLUSION: The use of an acetate-buffered, balanced infusion solution results in reduced need for use of catecholamines and cumulative catecholamine dose for hemodynamic support and in less occurrence of arterial hypotension in the perioperative period. Further research in the field is strongly encouraged. Springer Vienna 2017-03-02 2017 /pmc/articles/PMC5599439/ /pubmed/28255797 http://dx.doi.org/10.1007/s00508-017-1180-4 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Pfortmueller, Carmen
Funk, Georg-Christian
Potura, Eva
Reiterer, Christian
Luf, Florian
Kabon, Barbara
Druml, Wilfred
Fleischmann, Edith
Lindner, Gregor
Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial
title Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial
title_full Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial
title_fullStr Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial
title_full_unstemmed Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial
title_short Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial
title_sort acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: prospective, randomized, controlled trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599439/
https://www.ncbi.nlm.nih.gov/pubmed/28255797
http://dx.doi.org/10.1007/s00508-017-1180-4
work_keys_str_mv AT pfortmuellercarmen acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial
AT funkgeorgchristian acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial
AT poturaeva acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial
AT reitererchristian acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial
AT lufflorian acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial
AT kabonbarbara acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial
AT drumlwilfred acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial
AT fleischmannedith acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial
AT lindnergregor acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial